CDEK
← All drugs Report issue

nimustine

Small moleculeexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2016 (NCT02698280)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • DNACROSS-LINKING AGENT

    DNA cross-linking agent

  • DNADISRUPTING AGENT

    DNA disrupting agent

    Alkylating agent

Chemistry & pharmacology

Loading structure…

SMILES

Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1
Mol. weight
272.7 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • nimustine
  • nimustine
  • nimustine
  • nimustine
  • nimustine
  • nimustine
  • nimustine
  • nimustine
  • nimustine hcl
  • nimustine hcl
  • nimustine hcl
  • nimustine hydrochloride

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02698280Phase 2Jan 1, 2016Fudan University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Fudan UniversityAcademic/Hospital1112016
1 organizations
Page 1 / 1